UMIN ID: UMIN000001540
Registered date:02/12/2008
A Phase I Dose Intensification Study of three dimentional conformal thoracic radiotherapy with concurrent cisplatin and TS-1 for unresectable stage III non-small cell lung cancer
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | non-small cell lung cancer |
| Date of first enrollment | 2007/09/01 |
| Target sample size | 27 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Chemo-Radiotherapy |
Outcome(s)
| Primary Outcome | To determin Maximum Torelated Dose and Recommended dose of thoracic radiotherapy for stage III NSCLC. |
|---|---|
| Secondary Outcome | Toxicity, Response rate, Survival |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 75years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Interstitial pneumonia. No eligibility for definitive radiotherapy. |
Related Information
| Primary Sponsor | Shizuoka Cancer Center, The Cancer Institute Hospital of JFCR |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | None |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | Japan |
| Telephone | |
| h.harada@scchr.jp | |
| Affiliation | Shizuoka Cancer Center Radiation Oncology |
| scientific contact | |
| Name | Hideyuki Harada |
| Address | Shimonagakubo 1007, Nagaizumi-cho, Sunto-Gun, Shizuoka, Japan Japan |
| Telephone | |
| Affiliation | Shizuoka Cancer Center Radiation Oncology |